| Dr Meredith Collin Holderfield, PHARMD | |
|
1204 Se 28th St, Suite 2, Bentonville, AR 72712-3881 | |
| (888) 414-5805 | |
| (855) 422-2400 |
| Full Name | Dr Meredith Collin Holderfield |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1204 Se 28th St, Bentonville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225318793 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Meredith Collin Holderfield, PHARMD 1204 Se 28th St, Suite 2, Bentonville, AR 72712-3881 Ph: (479) 250-1443 | Dr Meredith Collin Holderfield, PHARMD 1204 Se 28th St, Suite 2, Bentonville, AR 72712-3881 Ph: (888) 414-5805 |
News Archive
Doctors at the Texas Heart Institute at St. Luke's Episcopal Hospital announced that they have performed an investigational procedure on six patients in a new FDA-approved clinical trial to evaluate therapy that uses regenerative cells derived from a patient's own adipose (body fat) tissue to treat a severe form of heart failure.
A new policy recommendation released on 20 July by the World Health Organization (WHO) warns against the use of serological (blood) tests to diagnose active tuberculosis.
Traumatic brain injury - not heart disease, stroke or cancer - is the number one cause of death and disability in people under 45. Each year, some 1.5 million Americans, including soldiers, athletes, the elderly and children, sustain head injuries, and nearly half of them will be hospitalized and treated in an emergency room or intensive care unit.
A new study describes a therapeutic approach to halting cancer progression by exploiting a previously unrecognized "addiction" of leukemia cells to specific signaling molecules. The research, published by Cell Press online on April 16th in the journal Cancer Cell, identifies non-classical oncogenes critical for tumor development and survival, and describes a potentially less toxic strategy that selectively targets these molecules.
› Verified 1 days ago
Michael Fertig, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2730 Sw Livingston Sq, Bentonville, AR 72713 Phone: 214-578-3685 | |
Jessie Joann Kruse, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1204 Se 28th St Ste 2, Bentonville, AR 72712 Phone: 888-414-5805 Fax: 855-422-2400 | |
Darren Keith Townzen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 702 Sw 8th St, Bentonville, AR 72712 Phone: 479-381-6136 | |
Rane Dearing, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3510 Se 14th St, Bentonville, AR 72712 Phone: 479-621-6470 Fax: 479-621-6461 | |
Pierce Wyland Skersick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2805 Mid Cities Dr, Bentonville, AR 72712 Phone: 479-271-7634 | |
Tatum Bishop, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3510 Se 14th St, Bentonville, AR 72712 Phone: 479-621-9470 | |
Mr. Kirk Eugene Milam, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 316 Nw Lasalle Dr, Bentonville, AR 72712 Phone: 479-271-9007 |